Skip to main content
logo
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.470
-0.350 (-9.16%)
At close: Oct 23, 2026, 4:00 PM EDT
3.610
+0.140 (4.03%)
Pre-market: Oct 26, 2026, 5:39 AM EDT

Opus Genetics Revenue

Opus Genetics had revenue of $755.00K in the quarter ending June 30, 2026, a decrease of -73.80%. This brings the company's total for the last twelve months to $9.86M, down -36.09% year-over-year. In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth. That makes Opus Genetics the 37,442nd largest company in the world by revenue and 4,912th in the United States.

Revenue (ttm)
$9.86M
Revenue Growth
-36.09%
P/S Ratio
29.29
Revenue / Employee
$352,000
Employees
28
Market Cap
288.69M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Agenus132.69M
Fulcrum Therapeutics80.00M
Scribe Therapeutics33.30M
Arcturus Therapeutics Holdings29.37M
Alector13.86M
Vicore Pharma Holding AB412.09K
Artiva Biotherapeutics251.00K
Inhibikase Therapeutics1.00
Revenue Rankings

IRD News

More News